Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
多瑞醫葯
301075
5
德邁仕
301007
(Q1)2003/06/30 | (FY)2003/03/31 | (Q4)2003/03/31 | (Q3)2002/12/31 | (Q2)2002/09/30 | (Q1)2002/06/30 | (FY)2002/03/31 | (Q4)2002/03/31 | (Q3)2001/12/31 | (Q2)2001/09/30 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 10.14%316.99萬 | -32.96%921.26萬 | -33.27%208.23萬 | -41.36%197.15萬 | -38.70%226.39萬 | -22.35%287.81萬 | -19.53%1,374.18萬 | 6.46%312.04萬 | -31.86%336.17萬 | -29.88%369.3萬 |
營業收入 | 10.14%316.99萬 | -32.96%921.26萬 | -33.27%208.23萬 | -41.36%197.15萬 | -38.70%226.39萬 | -22.35%287.81萬 | -19.53%1,374.18萬 | 6.46%312.04萬 | -31.86%336.17萬 | -29.88%369.3萬 |
主營業務成本 | 19.14%218.24萬 | -30.96%738.98萬 | -6.56%303.68萬 | -51.81%128.35萬 | -52.74%121.89萬 | -21.63%183.18萬 | -27.28%1,070.35萬 | -8.97%325.01萬 | -31.13%266.36萬 | -38.45%257.91萬 |
毛利 | -5.61%98.75萬 | -40.01%182.28萬 | -636.15%-95.45萬 | -1.46%68.79萬 | -6.18%104.5萬 | -23.58%104.63萬 | 28.93%303.83萬 | 79.71%-12.97萬 | -34.52%69.81萬 | 3.49%111.39萬 |
營業費用 | -25.43%84.14萬 | -14.54%325.28萬 | -149.71%-8.59萬 | -0.28%102.49萬 | -20.76%111.29萬 | -5.39%112.84萬 | 17.33%380.62萬 | 146.33%17.29萬 | -20.35%102.78萬 | 14.89%140.45萬 |
銷售和管理費用 | -29.50%72.33萬 | -18.46%278.47萬 | -162.73%-13.54萬 | -3.91%86.38萬 | -22.82%96.94萬 | -0.96%102.59萬 | 16.71%341.5萬 | 153.93%21.59萬 | -24.96%89.9萬 | 11.80%125.59萬 |
折舊攤銷及損耗 | 3.75%11.81萬 | 19.64%46.8萬 | 215.13%4.95萬 | 25.12%16.11萬 | -3.42%14.35萬 | -27.36%11.39萬 | 23.12%39.12萬 | -258.72%-4.3萬 | 39.39%12.88萬 | 49.94%14.86萬 |
-折舊及攤銷 | 3.75%11.81萬 | 19.64%46.8萬 | 215.13%4.95萬 | 25.12%16.11萬 | -3.42%14.35萬 | -27.36%11.39萬 | 23.12%39.12萬 | -258.72%-4.3萬 | 39.39%12.88萬 | 49.94%14.86萬 |
其他營業費用 | ---- | ---- | ---- | ---- | ---- | ---1.14萬 | ---- | ---- | ---- | ---- |
營業利潤 | 277.95%14.61萬 | -86.21%-143萬 | -187.07%-86.86萬 | -2.24%-33.7萬 | 76.64%-6.79萬 | -146.53%-8.21萬 | 13.45%-76.79萬 | -13.77%-30.26萬 | -47.11%-32.96萬 | -98.79%-29.07萬 |
淨非營業利息收入(費用) | ||||||||||
其他淨收入(費用) | 105.88%1.55萬 | -668.56%-38.82萬 | -1,079.76%-42.56萬 | 563.70%1.95萬 | -42.95%1.06萬 | -33.69%7,530 | -72.28%6.83萬 | 39.39%4.34萬 | -98.49%2,945 | 728.75%1.85萬 |
特殊收入(費用) | 105.88%1.55萬 | -668.56%-38.82萬 | -1,079.76%-42.56萬 | 563.70%1.95萬 | -42.95%1.06萬 | -33.69%7,530 | -72.28%6.83萬 | 39.39%4.34萬 | -98.49%2,945 | 728.75%1.85萬 |
稅前利潤 | 217.70%13.04萬 | -135.25%-196.22萬 | -368.61%-132.57萬 | 3.76%-36.63萬 | 68.75%-8.93萬 | -170.10%-11.08萬 | -10.78%-83.41萬 | -28.29萬 | -38.07萬 | -13.44%-28.59萬 |
所得稅 | -95.59%627 | 21.65%-27.99萬 | -28.41萬 | -9,997 | ||||||
除稅後利潤 | 217.04%13.04萬 | -626.20%-196.22萬 | -242.75%-132.51萬 | 1.16%-36.63萬 | 68.75%-8.93萬 | -177.46%-11.14萬 | 176.86%37.29萬 | 22,543.88%92.83萬 | -629.31%-37.07萬 | -13.44%-28.59萬 |
持續經營利潤 | 217.04%13.04萬 | -254.08%-196.22萬 | -107,137.00%-132.51萬 | 1.16%-36.63萬 | 68.75%-8.93萬 | -177.46%-11.14萬 | -40.06%-55.42萬 | -98.55%1,238 | -629.31%-37.07萬 | -13.44%-28.59萬 |
稅項虧損所得淨額結轉 | ---- | ---- | ---- | ---- | ---- | ---- | --92.7萬 | ---- | ---- | ---- |
歸屬於少數股東的淨利潤 | ||||||||||
歸屬於母公司的淨利潤 | 217.04%13.04萬 | -626.20%-196.22萬 | -242.75%-132.51萬 | 1.16%-36.63萬 | 68.75%-8.93萬 | -177.46%-11.14萬 | 176.86%37.29萬 | 22,543.88%92.83萬 | -629.31%-37.07萬 | -13.44%-28.59萬 |
優先股派息 | ||||||||||
其他優先股派息 | ||||||||||
歸屬於普通股股東的淨利潤 | 217.04%13.04萬 | -626.20%-196.22萬 | -242.75%-132.51萬 | 1.16%-36.63萬 | 68.75%-8.93萬 | -177.46%-11.14萬 | 176.86%37.29萬 | 22,543.88%92.83萬 | -629.31%-37.07萬 | -13.44%-28.59萬 |
基本每股收益 | 200.00%0.01 | -700.00%-0.12 | -233.33%-0.08 | 0.00%-0.02 | 50.00%-0.01 | -200.88%-0.01 | 150.00%0.02 | 0.06 | -420.02%-0.02 | 0.00%-0.02 |
稀釋每股收益 | 200.00%0.01 | -700.00%-0.12 | -233.33%-0.08 | 0.00%-0.02 | 50.00%-0.01 | -200.88%-0.01 | 150.00%0.02 | 20,718.56%0.06 | -420.02%-0.02 | 0.00%-0.02 |
每股派息 | ||||||||||
貨幣單位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
審計意見 | -- | 無保留意見 | -- | -- | -- | -- | 無保留意見 | -- | -- | -- |